Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02725255Phase 3Completed
Phase 3, randomised, double-blind trial in helminthiasis, tinea capitis and anemia (3 arms), sponsored by Kenya Medical Research Institute. Primary endpoint: parasite egg count at 60 days. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02725255.